Results for tag: "NASH Biomarker"

NASH biomarkers are a type of biomarker used to diagnose and monitor non-alcoholic steatohepatitis (NASH). NASH is a chronic liver disease that is characterized by the accumulation of fat in the liver, inflammation, and fibrosis. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. NASH biomarkers are used to diagnose NASH, to monitor the progression of the disease, and to assess the effectiveness of treatments. NASH biomarkers are typically measured in the blood or urine, and can include markers of liver injury, inflammation, fibrosis, and metabolic dysregulation. Examples of NASH biomarkers include alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), and C-reactive protein (CRP). The NASH biomarker market is a rapidly growing market, driven by the increasing prevalence of NASH and the need for more accurate and reliable diagnostic and monitoring tools. Companies in the NASH biomarker market include Bio-Rad Laboratories, Siemens Healthineers, Abbott Laboratories, and Roche Diagnostics. Show Less Read more